Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FHF complex subunit HOOK-interacting protein 2B (FHIP2B) is a protein-coding gene with regulatory roles in cellular signaling pathways, notably activating MAPK/ERK and TGFB signaling[2][12][13]. It may modulate gene activity related to intestinal barrier integrity and immunoprotection, and potentially has a role in cell proliferation[2][12]. FHIP2B is associated with certain cancers, acting as a tumor marker in hepatocellular carcinoma and being linked to colon lymphoma[2][6]. It is classified as a member of a protein complex (FHF complex) but is not an enzyme, receptor, transporter, ion channel, or transcription factor. There are presently no known drugs directly targeting FHIP2B, nor is it established as a classic therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FHF complex subunit HOOK-interacting protein 2B (FHIP2B).